MI
Macy's, Inc. (M)·Q2 2026 Earnings Summary
Executive Summary
- Q2 2026 beat on both top and bottom line: total revenue $4.999B vs consensus ~$4.702B, GAAP EPS $0.31 vs consensus ~$0.19; adjusted EPS $0.41, above guidance, driven by comps growth and disciplined SG&A . Consensus values marked with an asterisk; Values retrieved from S&P Global.*
- Gross margin rate contracted 80 bps YoY to 39.7% on proactive markdowns of early spring inventory and flow-through of product bought under prior tariff rates; SG&A dollars fell $29M, but rose 20 bps as a percent of revenue due to lower net sales .
- Nameplate performance was mixed: Macy’s comps +1.2% (O+L+M) with go-forward stores +1.5%; Bloomingdale’s comps +5.7% (O+L+M); Bluemercury comps +1.2% .
- Guidance raised: FY net sales to $21.15–$21.45B (from $21.0–$21.4B) and adjusted EPS to $1.70–$2.05 (from $1.60–$2.00); tariff impact on gross margin increased to 40–60 bps from 20–40 bps .
- Balance sheet actions extended maturities and reduced net long-term debt ~$340M; cash $829M, total debt $2.6B at quarter end; dividend declared ($0.1824/sh) and buybacks resumed ($50M in Q2) .
What Went Well and What Went Wrong
What Went Well
- Strongest comps in 12 quarters across the enterprise; go-forward business comps +2.2% (O+L+M), with Reimagine 125 stores outperforming broader fleet. “Our performance highlights the advantages of being a multi-brand, multi-category, omni-channel retailer.” — Tony Spring .
- Luxury momentum: Bloomingdale’s net sales +4.6%, comps +5.7% (O+L+M) with record second-quarter NPS; Bluemercury delivered its 18th consecutive positive comps quarter (+1.2%) .
- Credit card revenues +$28M YoY to $153M on healthy credit portfolio and prudent management of net losses; other revenue +18% YoY to $187M .
What Went Wrong
- Gross margin rate down 80 bps YoY to 39.7% on proactive markdowns and tariff pass-through; adjusted EBITDA margin down to 7.9% (from 8.6%) .
- Net sales decreased 2.5% YoY to $4.812B, reflecting impact of store closures (~$170M YoY headwind) despite positive comps at nameplates .
- Tariff headwinds increased: management now embeds 40–60 bps gross margin impact for FY (prior 20–40 bps), implying ~$0.25–$0.40 EPS drag vs prior $0.10–$0.25; majority of incremental impact expected in Q4 .
Financial Results
Performance vs prior periods
Q2 2026 vs Wall Street consensus (S&P Global)
Values retrieved from S&P Global.*
Segment and comps breakdown (Q2 2026)
KPIs and revenue composition (Q2 2026)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Our strongest comparable sales growth in 12 quarters… gives us further confidence that our Bold New Chapter initiatives can drive sustainable, long-term profitable growth.” — Tony Spring, CEO .
- “Adjusted EPS of $0.41 was above our guidance… reflecting comparable sales growth, disciplined expense controls, and tariff mitigation actions.” — Tony Spring .
- “SG&A expense of $1.9B declined $29M… partially offset by investments in the go-forward business, including Reimagine 125 and Bloomingdale’s.” — 8-K .
- “We recently completed financing transactions… net long-term debt reduced by ~$340M; no meaningful maturities until 2030.” — Tom Edwards, CFO .
Q&A Highlights
- Consumer tone: “Choiceful but resilient”; strong July and back-to-school start; cautious guidance given tariff uncertainty .
- Tariffs/pricing: Surgical price increases; vendor discounts, shared cost negotiations; tariff impact raised to 40–60 bps with majority hitting Q4 .
- Reimagine 125: Both first 50 and next 75 delivered positive comps; local empowerment, staffing, and visual storytelling driving NPS and AOV .
- Luxury share gains: Bloomingdale’s taking share across categories; collaborations and format expansion (Bloomies/outlets) .
- SG&A leverage: Always-on savings enable reinvestment; FY SG&A dollars guided down while continuing growth investments .
Estimates Context
- Q2 2026 results materially beat consensus on revenue and EPS; consensus EPS ~$0.19 vs actual $0.31; consensus revenue ~$$4.70B vs actual $4.999B. Number of estimates: EPS 13; Revenue 6.*
- Prior quarter (Q1 2026) also exceeded: EPS ~$0.15 vs $0.16; revenue ~$4.43B vs $4.79B.*
- Implication: Street may need to revise FY EPS upward within raised company range ($1.70–$2.05), while reflecting increased tariff drag (40–60 bps) and Q4-weighted impact .
Values retrieved from S&P Global.*
Key Takeaways for Investors
- Beat-and-raise quarter: Broad-based comps strength and tighter expense control drove upside; FY guide raised on sales and adjusted EPS despite heightened tariff headwinds .
- Mix shift benefits: Luxury (Bloomingdale’s/Bluemercury) continues to outpace; go-forward Macy’s and R125 outperform, supporting margin recovery potential as private brand penetration rebuilds .
- Near-term margin pressure: Gross margin contracted 80 bps YoY and tariff impact increased to 40–60 bps; expect Q4 to bear majority of incremental tariff hit .
- Balance sheet resilience: Maturities extended; net long-term debt reduced; continued shareholder returns via dividends and buybacks support capital flexibility .
- Trading setup: Into Q3, guidance embeds cautious comps (down ~1.5% to up ~0.5%) and EPS loss, but momentum continues quarter-to-date; watch tariff mitigation, pricing elasticity, and holiday execution .
- Estimate revisions: Expect upward EPS revisions toward company’s raised range; Street needs to incorporate higher tariff drag and stronger credit revenue outlook .
- Medium-term thesis: Execution on Bold New Chapter—expansion of private brands, R125 rollout, luxury share gains, and end-to-end efficiencies—positions Macy’s for improved margins and sustainable growth post-tariff normalization .